Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Laurence Fink notes shift in U.S. regulator’s focus to product regulation

Thursday, June 19, 2014

Komfie Manalo, Opalesque Asia:

Market regulators in the U.S. are shifting their focus and are adopting BlackRock Inc.’s strategy to concentrate on products rather than on asset managers, claimed Laurence D. Fink, chief executive officer of the world’s biggest money manager.

He was quoted by Bloomberg as saying, "We’d been a huge advocate and we had many conversations with many regulators about the need to focus more on product regulation." Speaking at BlackRock’s investor conference in New York, Fink noted that "regulators are being refocused" on products.

He said this refocus on regulation has significant implications on the hedge fund industry.

BlackRock has been lobbying Congress not to label the firm as a systemically important financial institution, or SIFI. This, as a group of regulators comprising the Financial Stability Oversight Council, led by Treasury Secretary Jacob J. Lew, is studying if they will designate asset managers for oversight by the Federal Reserve.

In May, BlackRock has called on regulators to set best practices for the way funds are structured globally and to review investor redemption rules in different markets.

BlackRock's suggestions come as regulators in the U.S. ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its